Skip to main content
Equibles

Huma Qamar

Ocugen, Inc. (OCGN)

Equibles does not estimate personal net worth.

Get an email with a short summary when Ocugen, Inc. publishes a filing, an earnings call transcript or a press release.

Get OCGN alerts

About Huma Qamar

The proxy statement of Ocugen, Inc. reports total compensation of $2,888,481 for Huma Qamar in fiscal 2025, including a base salary of $448,050. Disclosed compensation is on record for 2 fiscal years. Huma Qamar has spoken on 1 earnings call across 1 company, most recently for Ocugen, Inc. on May 5, 2026. Ocugen, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Ocugen, Inc. includes Shankar Musunuri (CEO), Quan Anh Vu (CFO), Ramesh Ramachandran (CFO and Chief Accounting Officer) and 6 others.

Huma Qamar on recent calls

“So both represent inherited retinal diseases, of course, retinitis, pigmentosa. You know, we have almost the same centers. There is a single subretinal injection.”
Other, Ocugen, Inc. Q1 FY2026 Earnings Call ·

Affiliation history

Company network

Leadership on record at Ocugen, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Ocugen, Inc. (OCGN) $448,050 $2,888,481
2024 Ocugen, Inc. (OCGN) $344,375 $1,725,701

Recent activity